RxDoctor Payments Data

Dan Wajsman, MD

Anesthesiology · Walnut Creek, CANPI 1740226695

Payments from drug & device makers

$853in general payments, 2019–2025

Across 35 payments — averaging $24.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Celltrion USA Inc.$185
  • Takeda Pharmaceuticals U.S.A., Inc.$181
  • Lilly USA, LLC$172
  • Phathom Pharmaceuticals, Inc.$91
  • Sanofi$58
  • Acacia Pharma Inc$49
  • plus $117 from 5 others

What the payments were for

  • Food & beverage$80694%
  • Education$476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$853 in reported general payments places this provider in the 85th percentile of 5,717 anesthesiology providers in California.

See all anesthesiology providers in California

Medicare billing

Part B allowed, 2024
$54,659
Medicare patients
391
Services billed
395

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anesthesiology in Walnut Creek

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →